Mortality and cancer experience of Quebec aluminum reduction plant workers, part 2: Mortality of three cohorts hired on or before January 1, 1951

Journal of Occupational and Environmental Medicine

Volumn 49, Issue 10, 2007, Pages 1105-1123

  Gibbs, Graham W ^a,b   Armstrong, Ben ^c   Sevigny, Maurice ^d  

^a Safety Health Environment International Consultants Corp   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Paragon Business Solutions Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; BENZENE; BENZO[A]PYRENE;

AGED; ALZHEIMER DISEASE; ARTICLE; BLADDER CANCER; CANADA; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLON CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OCCUPATIONAL EXPOSURE; PANCREAS CANCER; RECTUM CANCER; SMELTER; SMOKING; STATISTICAL SIGNIFICANCE; STOMACH CANCER;

EID: 36048978763     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e318157d34a     Document Type: Article

References (42)

1. Ravier EF. Technology of alumina reduction. In: Hughes JP, ed. Health Protection in Primary Aluminium Production, Proceedings of a Seminar, Copenhagen 28-30 June 1977. London: IPAI; 1977:17-21.
2. IARC. IARC Monographs on the evaluation of carcinogenic risk of chemicals to humans. Polynuclear aromatic compounds, Part 3, Industrial Exposures in Aluminium Production, Coal Gasification, Coke Production and Iron and Steel Founding. Volume 34. Lyon, France: IARC; 1984.
3. Gibbs GW, Horowitz I. Lung cancer mortality in aluminum reduction plant workers. J Occup Med. 1979;21:347-353.
4. Gibbs GW. Mortality experience in Eastern Canada. In: Hughes JP, ed. IPAI, Health Protection in Primary Aluminum Production 2. Proceedings of a Seminar, Montréal 22-24 September 1981. 1982:59-69.
5. Gibbs GW. Mortality of aluminum reduction plant workers, 1950 through 1977. J Occup Med 1985;27:761-770.
6. Theriault G, DeGuire L, Cordier S. Reducing aluminum: an occupation possibly associated with bladder cancer. Can Med Assoc J. 1981;124:419-425.
7. Theriault G, DeGuire L, Cordier S, et al. Bladder cancer in the aluminum industry. Lancet 1984;947-950.
8. Tremblay C, Armstrong B, Brodeur J, Theriault G. Estimation of risk of developing bladder cancer among workers exposed to coal tar pitch volatiles in the primary aluminum industry. Am J Industr Med 1995;27:335-348.
9. Armstrong BG, Tremblay CG, Cyr D, Thériault GP. Estimating the relationship between exposure to tar volatiles and the incidence of bladder cancer in aluminum smelter workers. Scand J Work Environ Health 1986;12:486-493.
10. Armstrong B, Tremblay C, Baris D, Thériault G. Lung cancer mortality and polynuclear aromatic hydrocarbons: a case-cohort study of aluminum production workers in Arvida, Quebec, Canada. Am J Epidem. 1994;139:250-262.
11. Konstantinov VG, Simakhina PG, Gotlib EV, Kuz'minykh AI. Problem of the carcinogenic hazard in aluminum electrolysis halls. Professional'nyi Rak. 1974;87-91.
12. Enterline PE. (1981) Mortality experience in the United States. In: Hughes JP, ed. IPAI, Health Protection in Primary Aluminum Production 2. Proceedings of a Seminar, Montréal 22-24 September 1981. London: IPAI; 1982:53-58.
13. Andersen A, Dahlber BE, Magnus K, et al. Risk of cancer in Norwegian aluminum industry. Int J Cancer. 1982;29:295-298.
14. Ronneberg A, Langmark F. Epidemiologic evidence of cancer in aluminum reduction workers. Am J Ind Med 1992;22:573-590.
15. Ronneberg A, Andersen A. Mortality and cancer morbidity in workers from an aluminum smelter with prebaked carbon anodes - Part II: Cancer Morbidity. Occup Environ Med 1995;52:250-254.
16. Milham S. Mortality in aluminum reduction workers. J Occup Med 1979;21:475-480.
17. Rockette HE, Arena VC. Mortality studies of aluminum reduction plant workers: potroom and carbon department. J Occup Med 1983;25:549-557.
18. Romundstad P, Haldorsen T, Andersen A. Cancer incidence and case specific mortality among workers in two Norwegian aluminum reduction plants. Am J Industr Med 2000;37:175-183.
19. Moulin JJ, Clavel T, Buclez B, Lafitte-Rigaud G. A mortality study among workers in a French aluminum reduction plant. Int Arch Environ Health. 2000;73:323-330.
20. Spinelli J, Band PR, Svirchev LM, Gallagher RP. Mortality and cancer incidence in aluminum reduction workers. J Occup Med 1991;33:1150-1155.
21. Spinelli JJ, Demers PA, Le ND, et al. Cancer risk in aluminum reduction plant workers (Canada) cancer causes control 2006;17:929-948.
22. Gibbs GW. Occupational cancer overview: aluminum reduction. In: Priest ND and O'Donnell TV, eds. Health in the Aluminium Industry. London: Middlesex University Press; 1998:135-153.
23. Lavoué J, Gerin M, Cote J, Lapointe R. Mortality and cancer experience of Quebec aluminum reduction plant workers. Part 1- the reduction plants and coal tar pitch volatile exposure assessment. (submitted to JOEM) (2006).
24. Marsh GM, Preininger ME. OCMAP: a user-oriented occupational cohort mortality analysis program. Am Stat. 1980;34:245.
25. Marsh GM, Youk AO, Stone RA, et al. OCMAP-PLUS: a program for the comprehensive analysis of occupational cohort data. J Occup Environ Med. 1998;40:351-362.
26. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume II. Lyon: IARC Scientific Publications No 82; 1987:406.
27. Farant JP, Ogilvie D. Investigation of the presence of amino and nitro polycyclic aromatic hydrocarbons in a Soderberg primary aluminum smelter. AIHA. 2002;63:721-725.
28. Michaud DS, Spiegelman D, Clinton SK, et al. Fluid intake and the risk of bladder cancer in men. New Engl J Med. 1999;340:1390-1397.
29. LeBel G, Gingras S, Levallois P, Gauthier R, Gagnon M-F. Etude descriptive de líncidence du cancer au Québec de 1989 à 1993. National Library of Canada ISBN:2-89496-053-0; 1998.
30. Surveillance de la mortalité au Québec. Collection 14. Analyses et surveillance. Quebéc: Ministère de la Santé et des Services sociaux March 2001:253.
31. Agence de santé et des services sociaux du Saguenay -Lac St Jean. Tableaux synoptique des indicateurs sociosanitaires par territoire. Le Quebec, le Saguenay-Lac-Saint-Jean et ses territories sociosanitaires. Chicoutimi. Gouvernement du Quebec, 2005:40.
32. Carta P, Aru G, Cadeddu C, et al. Mortality for pancreatic cancer among aluminum smelter workers in Sardinia, Italy. G Ital Med Lav Ergon. 2004;26:83-89.
33. Conrath SM. The use of epidemiology, scientific data and regulatory authority to determine risk factors in cancer for some organs of the digestive system. Reg Toxicol Pharmacol. 1986;6:193-210.
34. Howe GR, Jain M, Burch JD, et al. Cigarette smoking and cancer of the pancreas: evidence from a population based case-control study in Toronto Canada. Int J Cancer. 1991;47:323-328.
35. Becher H, Ramroth H, Ahrens W, et al. Occupation, exposure to polycyclic aromatic hydrocarbons and laryngeal cancer risk. Int J Cancer. 2005;116:451-457.
36. Gauthier E, Emard J-F, Thouez J-P, Gauvreau. Possible links between the physicochemical characteristics of drinking water and dementia of the Alzheimer type in a region of Quebec, Canada. In: Majumdar SK, Miller EW, Brenner FJ, eds. Environmental Contaminants Ecosystems and Human Health. Eaton, Pennsylvania: Pennsylvania Academy of Science; 1995:374-394.
37. Gauthier E, Fortier I, Courchesne F, et al. Monomeric organic aluminum as a risk factor for Alzheimer's disease. In: Priest ND, O'Donnel TV, eds. Proceedings of International Conference on Managing Health Issues in the Aluminum Industry. London, England: Middlesex University Press; 1997;26-29.
38. De Braekeleer M, Cholette A, Mathieu J, et al. Familial factors in Alzheimer's disease (IMAGE project). A case-control study in the Saguenay Lac St Jean region. European Neurology. 1989;29(Suppl 3):2-8.
39. Gauvreau D, DeBraekeleer M, Bouchard R, et al. The IMAGE project: a multimatrix model for the study of Alzheimer's disease. In: Blass JP, Miner G, Miner LA, Richter RN eds. Familial Alzheimer's Disease. Molecular Genetics and Clinical Perspectives. New York: Valentine/Dekker; 1989;3:331-365.
40. Gupta VB, Anitha S, Hegde ML, et al. Aluminium in Alzheimer's disease: are we at a crossroad? Cell Mol Life Sci. 2005;62:143-158.
41. Gibbs GW. Estimating residential polycyclic aromatic hydrocarbon (PAH) related lung cancer risks using occupational data. Ann Occup Hyg. 1997;41(Suppl 1):49-53.
42. Armstrong B, Hutcheson E, Unwin, et al. Lung cancer risk after exposure to polycyclic aromatic hydrocarbons: a review and meta-analysis. Environ Health Perspect. 2004;112:970-978.